USPTO serial 79362823
CELADON
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEELEY,ALISON REBECCA
- Law office
- TMO LAW OFFICE 113
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELADON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
PETER J WILLSEY
PETER J WILLSEY BROWN RUDNICK LLP601 THIRTEENTH STREET NW SUITE 600WASHINGTON, DC 20005UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical products and medical preparations for the treatment of endometriosis, chronic pain, autism spectrum disorder, hemorrhoidal disease, bladder pain syndrome (interstitial cystitis), inflammatory bowel disease, rheumatoid arthritis, osteoarthritis, opioid use disorder, multiple sclerosis, chemo-induced nausea and vomiting, insomnia, sleep disorder, anxiety, depression, PTSD, eczema, psoriasis, cancer and epilepsy; food, dietary and nutritional supplements | ACTIVE | — |
| 010 | Inhalers for medical use | ACTIVE | — |
| 031 | Natural plants and trees; seedlings | ACTIVE | — |
| 044 | Cultivation and harvesting of plants, resins, oils and waxes for medical purposes; dispensary services in relation to pharmaceutical products and preparations for the treatment of endometriosis, chronic pain, autism spectrum disorder, hemorrhoidal disease, bladder pain syndrome (interstitial cystitis), inflammatory bowel disease, rheumatoid arthritis, osteoarthritis, opioid use disorder, multiple sclerosis, chemo-induced nausea and vomiting, insomnia, sleep disorder, anxiety, depression, PTSD, eczema, psoriasis, cancer and epilepsy; provision of medical services relating to the use of plants, resins, oils and waxes for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 8, 2026 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 19, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 19, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 19, 2024 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Dec 18, 2024 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Dec 18, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Nov 8, 2024 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Aug 3, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 26, 2024 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Jul 26, 2024 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Jul 26, 2024 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jul 15, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 14, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 28, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 28, 2024 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 28, 2024 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 28, 2024 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Dec 29, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 29, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 30, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 9, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 8, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |